Loading clinical trials...
Loading clinical trials...
A Phase 3, Randomized, Open Label, Controlled Multicenter Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months
Conditions
Interventions
MenACWY-CRM
DTaP-IPV/Hib
+3 more
Locations
46
United States
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Birmingham, Alabama, United States
15 Northwest Arkansas Pediatric Clinic 3383 N. Mana Court Suite 101
Fayetteville, Arkansas, United States
6 Children's Clinic of Jonesboro AR 800 South Church Street Suite 400 and 204
Jonesboro, Arkansas, United States
9 San Fernando Valley Research Associates 7111 Winnetka Avenue Suite 14
Canoga Park, California, United States
17 Edinger Medical Group Research Center 9900 Talbert Avenue Suite 204
Fountain Valley, California, United States
28 Madera Family Medical Group 1111 West 4th Street
Madera, California, United States
Start Date
November 1, 2009
Primary Completion Date
November 1, 2011
Completion Date
November 1, 2011
Last Updated
April 21, 2014
NCT01725217
NCT03694405
NCT04358731
NCT01896596
NCT02811120
NCT03089086
Lead Sponsor
Novartis Vaccines
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions